New oral treatment for rheumatoid arthritis
Novel first-in-class Therapeutics for Rheumatoid Arthritis
['FUNDING_SBIR_1'] · BIOTHERAPEUTICS, INC. · NIH-10696749
This study is working on a new pill to help people with rheumatoid arthritis by targeting a specific part of the immune system to reduce inflammation and improve symptoms.
Quick facts
| Phase | ['FUNDING_SBIR_1'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | BIOTHERAPEUTICS, INC. (nih funded) |
| Locations | 1 site (BLACKSBURG, UNITED STATES) |
| Trial ID | NIH-10696749 on ClinicalTrials.gov |
What this research studies
This research focuses on developing a novel oral therapeutic specifically designed for rheumatoid arthritis (RA). The approach combines advanced computational modeling with experimental techniques to create a small-molecule drug that targets a newly identified pathway involved in inflammation and immune response. By testing this drug in animal models, the researchers aim to demonstrate its effectiveness in reducing disease severity and inflammation. The ultimate goal is to provide a safer and more effective treatment option for patients suffering from RA.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with rheumatoid arthritis who are seeking new treatment options.
Not a fit: Patients with rheumatoid arthritis who are currently well-managed on existing therapies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a new, safer oral treatment option for patients with rheumatoid arthritis.
How similar studies have performed: While this approach is innovative, similar research has shown promise in developing new therapeutics for inflammatory diseases.
Where this research is happening
BLACKSBURG, UNITED STATES
- BIOTHERAPEUTICS, INC. — BLACKSBURG, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: BASSAGANYA-RIERA, JOSEP — BIOTHERAPEUTICS, INC.
- Study coordinator: BASSAGANYA-RIERA, JOSEP
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.